|
Volumn 26, Issue 35, 2008, Pages 5825-
|
Clinical importance of estrogen receptor β isoforms in breast cancer
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
ESTROGEN RECEPTOR BETA;
ESTROGEN RECEPTOR BETA 1;
ESTROGEN RECEPTOR BETA 2;
ESTROGEN RECEPTOR BETA 5;
ISOPROTEIN;
TAMOXIFEN;
UNCLASSIFIED DRUG;
BREAST CANCER;
CANCER RECURRENCE;
CANCER SURVIVAL;
CELLULAR DISTRIBUTION;
DISEASE FREE SURVIVAL;
ETHNICITY;
HORMONAL THERAPY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LETTER;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
BREAST NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
ESTROGEN RECEPTOR BETA;
ESTROGEN RECEPTOR MODULATORS;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
PREDICTIVE VALUE OF TESTS;
PROTEIN ISOFORMS;
REPRODUCIBILITY OF RESULTS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 57449115330
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.19.5909 Document Type: Letter |
Times cited : (9)
|
References (6)
|